Search

everythinglearnresearchcommunity

for

Search:↓

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Erlotinib can cause nonscarring hair loss and itchy skin.

Females had more chemotherapy side effects than males, with many being preventable.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Educating patients on phototrichogram increased satisfaction in androgenetic alopecia treatment.

CEC levels may be a useful marker for predicting prostate cancer progression.

EGFR inhibitors for lung cancer can cause severe skin issues.

Sentinel lymph node mapping is safe and effective for early-stage ovarian cancer but isn't yet standard practice.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

Surgeons' testosterone levels significantly increase during major head and neck cancer surgeries.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.